FDA clears drug for rare and deadly GI cancer developed by Canadian firm Zymeworks
Co-founder of Zymeworks calls approval “the dream that many said was not possible.”
Isabelle is a Vancouver-based writer with 5+ years of experience in communications and journalism and a lifelong passion for telling stories. For over two years, she has reported on all sides of the Canadian startup ecosystem, from landmark venture deals to public policy, telling the stories of the founders putting Canadian tech on the map.
Co-founder of Zymeworks calls approval “the dream that many said was not possible.”
Test your knowledge of Canadian tech news with The BetaKit Quiz for Nov. 22, 2024.
Startup claims it can provide document notarization in just seven minutes.
ZayZoon named scaleup of the year, while Verano.AI scoops up One to Watch and Most Promising Founder awards.
New CEO Marie Chevrier Schwartz sees Peerscale as the “graduating class of the TechTO ecosystem.”
Deal expected to expand Jiffy’s service to more Canadian markets.
Startup winners collectively took home more than $600,000 from the conference.
Test your knowledge of Canadian tech news with The BetaKit Quiz for Nov. 15, 2024.
Three-year revenue growth of nearly 13,000 percent earned the startup a spot on Deloitte’s Technology Fast 50.
The founder of exited startup Medesync wants to accelerate clinical research with AI.
Mike Moroz will head the division supporting the province’s tech industry and modernizing public services.
How Aquanow keeps crypto transactions flowing around the world.
Late-stage funding also faltered, accounting for a record low 21 percent of total investment dollars in Canada.
How the global rideshare company provided “the best possible business education.”
The deal marks the fourth acquisition for Canadian-founded AppDirect in the last two years.